openPR Logo
Press release

Electroceuticals/Bioelectric Medicine Market: New Business Opportunities & Investment Research Report | Forecast up to 2024

08-09-2017 10:59 PM CET | Health & Medicine

Press release from: Transparency Market Research - Pharmaceutical

Electroceuticals/Bioelectric Medicine Market: New Business

Electroceuticals are medical devices that affect changes in body functions by utilizing electrical impulses. Electroceuticals act as an alternative to drug-based remedies, and are expected to be the future gold standard of treatment of various diseases. Unlike other stimulators of the muscles or tissues, electroceuticals act on the basis of neurostimulation, which is the modulation of the nervous systems using electrical impulses. Current treatment options in several neurological disorders and other disease states depend upon drug-based medications, which are associated with considerable side effects and promises of delivery of results are not yet totally fulfilled. Electroceuticals have found applications in various diseases and disorders and are effective in treatment of these conditions in both invasive and non-invasive methods. These are considered a genuine replacement of drug-based medications in future.

The global electroceuticals/bioelectric medicine market is segmented based on product, device type, end-user, application, and region. In terms of product, the global electroceuticals/bioelectric medicine market is segmented into cardiac pacemakers, deep brain stimulators, implantable cardioverter defibrillators, cochlear implants, spinal cord stimulators, vagus nerve stimulators, and others. The implantable cardioverter defibrillators segment accounted for the largest share of the global electroceuticals/bioelectric medicine market.

Based on end-user, the global electroceuticals/bioelectric medicine market is segmented into hospitals, clinics, home care settings, and others. In terms of device type, the global electroceuticals/bioelectric medicine market is segmented into non-invasive electroceuticals and implantable electroceuticals. The implantable electroceuticals segment is expected to account for the largest share of the market. However, the non-invasive electroceuticals segment is projected to expand at a higher CAGR during the forecast period. Based on application, the global electroceuticals/bioelectric medicine market is segmented into arrhythmias, epilepsy, Parkinson’s disease, spinal cord disorders, and other applications.

View Report-

http://www.transparencymarketresearch.com/electroceuticals-bioelectric-medicine-market.html

Increasing global geriatric population, rising cost pressures of drug based medicines, growing interest from major pharmaceutical players in the electroceuticals segment, and increasing incidence and prevalence of neurological disorders and chronic diseases across the world are some of the factors likely to boost the growth of the global electroceuticals market during the forecast period. Major players such as GlaxoSmithKline plc have made significant investments in the electroceuticals segment and other organizations such as the National Institutes of Health (NIH) in the U.S. have shown great interest in the field of electroceuticals. Increasing incidence of neurological disorders such as epilepsy, Parkinson’s diseases, and other chronic diseases are expected to augment the electroceuticals/bioelectric medicine market during the forecast period from 2016 to 2024.

In terms of region, the global electroceuticals/biomedicine market is segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is expected to expand at the fastest CAGR during the forecast period due to higher prevalence of chronic diseases such as diabetes and hearing loss due to rapidly increasing geriatric population in China, Japan, and India, increasing incidence of neurological disorders, and rising adoption of neurostimulation techniques. North America dominated the global electroceuticals/bioelectric medicine market in 2015 owing to factors such as increasing adoption of neurostimulation techniques, new and technologically advanced products being introduced, rising awareness about electroceuticals/bioelectric medicine, and increasing neurological and chronic diseases.

Key players in the electroceuticals/bioelectric medicine market are Boston Scientific Corporation, Cochlear Limited, Medtronic plc, St. Jude Medical, Inc., Biotronik, Sonova Holding AG, LivaNova plc, ElectroCore LLC, Nevro Corporation, and Second Sight Medical Products, Inc. Other pharmaceutical companies such as GlaxoSmithKline plc have invested in the electroceuticals market, with increased focus on bringing new miniaturized electroceutical devices in the market.

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Electroceuticals/Bioelectric Medicine Market during 2016- 2024

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17426

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Electroceuticals/Bioelectric Medicine Market: New Business Opportunities & Investment Research Report | Forecast up to 2024 here

News-ID: 662794 • Views:

More Releases from Transparency Market Research - Pharmaceutical

Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2026
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from 2020 to 2030
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical

All 5 Releases


More Releases for Electroceuticals

UK Electroceuticals Market Size & Growth Analysis Report, 2019-2025
The UK electroceuticals market is expected to grow at a CAGR of 7.5% during the forecast period. UK has the highest number of cardiovascular diseases, coronary heart disease, stroke, heart failure, atrial fibrillation, and other heart patients in Europe. Prolonged diseases, such as arthritis, asthma, chronic obstructive pulmonary disease, diabetes, and other heart-related diseases put economic burden on the UK government, which includes cost of premature fatalities, hospital stay, and
Electroceuticals Market Size, Share and Forecast 2019-2025
The global electroceuticals market is expected to grow at a CAGR of 7.1% during the forecast period. The global electroceuticals market is expected to grow significantly owing to various factors such as rising incidence and prevalence rate of chronic diseases, and growing investment for the development of advanced electroceuticals by major players as well as the government. Increasing prevalence of neurological disorders such as epilepsy, Parkinson’s, Paraneoplastic Neurologic Syndrome, migraine,
US Electroceuticals Market Growth, Size & Forecast to 2025
The US contributes significantly to the growth of the electroceuticals market. The market growth is attributed to the rise in the prevalence of arrhythmia, growing number of neural disorders, and high prevalence of hearing loss. In addition, rising number of Parkinson’s disease and expected approvals for retinal implants in the US are anticipated to contribute significantly to the growth of electroceuticals market. The US has a high incidence and prevalence
UK Electroceuticals Market Size, Share & Forecast 2019-2025
UK has one of the finest healthcare systems in the EU region, which enables it to provide quality healthcare to the individuals. UK has the highest number of cardiovascular diseases, coronary heart disease, stroke, heart failure, atrial fibrillation, and other heart patients. According to British Heart Foundation, more than one-fourth of the fatalities in UK occur due to `, and it is responsible for around 1.6 million fatalities each year. Request
North American Electroceuticals Market Growth, Size & Forecast to 2025
The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative electroceutical devices, and growing adoption of minimally invasive/non-invasive surgeries for treatment of several diseases owing to growing awareness among patients related to electroceuticals. The geriatric population is more inclined to the risk of heart strokes. According to WHO, the incidence and prevalence rate of heart attacks are highest in North
Latin America Electroceuticals Market
Latin America registers the significant growth of the electroceutical market during the forecast period especially in the countries including Brazil, Mexico among others, attributing to various driving factors. The growing prevalence of ischemic heart disease, age-related and other hearing loss, and epilepsy is creating demand for electroceuticals, thereby, anticipated to drive the growth of electroceuticals market in Latin America. As per the Institute for Health Metrics and Evaluation, in